Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2003-07-29
2009-06-02
Stockton, Laura L. (Department: 1626)
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
C514S388000
Reexamination Certificate
active
07541477
ABSTRACT:
This invention relates to a benzimidazole derivative of the general formula [I][wherein B1, B2, and B3represent hydrogen atom or lower alkyl; R1and R2are same or different and represent lower alkyl, etc.; R3and R4represent hydrogen atom, etc.; W represents a 3 to 8-membered aromatic or alphatic heterocycle, etc.; and Ar represents a substituted or unsubstituted aromatic heterocycle, etc.] This compound functions as an antagonist to melanin-concentrating hormone receptor and is useful as a drug for central diseases, circulatory diseases and metabolic diseases.
REFERENCES:
patent: 2002/0107195 (2002-08-01), Gupta
patent: 2003/0078252 (2003-04-01), Sanner et al.
patent: 2004/0077628 (2004-04-01), Ishihara et al.
patent: 0 419 210 (1991-03-01), None
patent: 1256578 (2002-11-01), None
patent: 03-109378 (1991-05-01), None
patent: 2001-139574 (2001-05-01), None
patent: 2003-64056 (2003-03-01), None
patent: 93/03714 (1993-03-01), None
patent: 95/32967 (1995-12-01), None
patent: 01/21577 (2001-03-01), None
patent: 01/82925 (2001-11-01), None
patent: 02/02744 (2002-01-01), None
patent: 02/28835 (2002-04-01), None
patent: 02/60374 (2002-08-01), None
patent: 03/15769 (2003-02-01), None
patent: 03/45313 (2003-06-01), None
Keenan et al., CA 121:205342, 1994.
Shigeyuki Chaki et al., “Recent advances in feeding suppressing agents: potential therapeutic strategy for the treatment of obesity”, Expert Opinion on Therapeutic Patents, vol. 11, No. 11, pp. 1677-1692, XP002438303, ISSN: 1354-3776, 2001.
Fukami Takehiro
Ishihara Akane
Iwaasa Hisashi
Kanatani Akio
Moriya Minoru
Banyu Pharmaceutical Co. Ltd.
Stockton Laura L.
Wenderoth , Lind & Ponack, L.L.P.
LandOfFree
Antagonists to melanin-concentrating hormone receptor... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antagonists to melanin-concentrating hormone receptor..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antagonists to melanin-concentrating hormone receptor... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4140728